A broad range of chronic conditions are treated with the Volara System, which provides continuous positive expiratory pressure (CPEP) to expand your lungs and airways, along with continuous high-frequency oscillation pulses to free mucus plugs and make it easier to cough and breathe less effortfully. However, if you use the Volara System, it’s important to be aware that its manufacturer, Baxter International Inc., issued an Urgent Medical Device Correction for the Volara System and then a recall. This is a home care system prescribed by doctors when a patient needs a ventilator in the home environment. Unfortunately, it’s been found that use of the system comes with a possible risk of oxygen desaturation, as well as the danger of overexpansion resulting in lung tissue damage. If you were injured or a loved one was killed due to the malfunctioning of the Volara System, you should give the seasoned product liability lawyers of Moll Law Group a call. You may have grounds to sue for damages, and it is important to seek counsel.
Give Moll Law Group A Call About Injuries From Defective Products
Baxter voluntarily issued the Urgent Medical Device Correction after receiving a report of a patient suffering from oxygen desaturation while using the device at home. The device was recalled in a class 1 recall because the device poses serious risks such as lung infection that restricts oxygen to the brain, brain injury such as hypoxia, death, and choking on mucus.
Initially caregivers and patients were warned to continue to use Volara therapy as prescribed, but were supposed to monitor for respiratory distress signs such as an increase in breathing rate, bluish color around the mouth or inside it, wheezing, or changes in alertness, when using it. Patients were told potential issues could occur when using the device with a ventilator and adaptor or the patient circuit kit oscillation and lung expansion therapy.